The panel recommends a series of actions to minimize the impact of drug costs on patients while also promoting value-based pricing of newer drugs.
From: https://www.webmd.com/cancer/news/20180313/presidential-panel-costly-cancer-drugs-harm-care?src=RSS_PUBLIC
No comments:
Post a Comment